MiR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: A potential for therapeutic intervention

Breast Cancer Research

Volumn 13, Issue 2, 2011, Pages

  Srivastava, Niloo ^a   Manvati, Siddharth ^a,b   Srivastava, Archita ^a   Pal, Ranjana ^a   Kalaiarasan, Ponnusamy ^a,b   Chattopadhyay, Shilpi ^a   Gochhait, Sailesh ^a   Dua, Raina ^c   Bamezai, Rameshwar N K ^a,b  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b SHRI MATA VAISHNO DEVI UNIVERSITY   (India)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2; CISPLATIN; HISTONE H2AX; LIPOCORTIN 5; MICRORNA; MICRORNA 24 2; OLIGONUCLEOTIDE; PROTEIN BCL 2; PROTEIN H2AFX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; H2AFX PROTEIN, HUMAN; HISTONE; MIRN24 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER TISSUE; CELL STRAIN MCF 7; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; FLOW CYTOMETRY; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMAL CELL; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; COPY NUMBER VARIATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROTO ONCOGENE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HELA CELLS; HISTONES; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84860389231     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2861     Document Type: Article

References (48)

1. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Månér S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528. 10.1126/science.1098918, 15273396.
2. Perry GH, Tchinda J, McGrath SD, Zhang J, Picker SR, Cáceres AM, Iafrate AJ, Tyler-Smith C, Scherer SW, Eichler EE, Stone AC, Lee C. Hotspots for copy number variation in chimpanzees and humans. Proc Natl Acad Sci USA 2006, 103:8006-8011. 10.1073/pnas.0602318103, 1472420, 16702545.
3. Guryev V, Saar K, Adamovic T, Verheul M, van Heesch SA, Cook S, Pravenec M, Aitman T, Jacob H, Shull JD, Hubner N, Cuppen E. Distribution and functional impact of DNA copy number variation in the rat. Nat Genet 2008, 40:538-545. 10.1038/ng.141, 18443591.
4. Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet 2007, 18:R1-R8.
5. Dopman EB, Hartl DL. A portrait of copy-number polymorphism in Drosophila melanogaster. Proc Natl Acad Sci USA 2007, 104:19920-19925. 10.1073/pnas.0709888104, 2148398, 18056801.
6. Shlien A, Malkin D. Copy number variations and cancer. Genome Med 2009, 1:62. 10.1186/gm62, 2703871, 19566914.
7. Goodheart MJ, Rose SL, Hattermann-Zogg M, Smith BJ, De Young BR, Buller RE. BRCA2 alteration is important in clear cell carcinoma of the ovary. Clin Genet 2009, 76:161-167. 10.1111/j.1399-0004.2009.01207.x, 19656163.
8. Srivastava N, Gocchait S, Gupta P, Bamezai R. Copy number alteration of H2AFX gene in sporadic breast cancer patients. Cancer Genet Cytogenet 2008, 180:121-128. 10.1016/j.cancergencyto.2007.09.024, 18206537.
9. Díaz de Ståhl T, Hansson CM, de Bustos C, Mantripragada KK, Piotrowski A, Benetkiewicz M, Jarbo C, Wiklund L, Mathiesen T, Nyberg G, Collins VP, Evans DG, Ichimura K, Dumanski JP. High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas. Hum Genet 2005, 118:35-44.
10. Shlien A, Tabori U, Marshall CR, Pienkowska M, Feuk L, Novokmet A, Nanda S, Druker H, Scherer SW, Malkin D. Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad Sci USA 2008, 105:11264-11269. 10.1073/pnas.0802970105, 2516272, 18685109.
11. Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA doublestrand breaks in vivo. J Cell Biol 1999, 146:905-916. 10.1083/jcb.146.5.905, 2169482, 10477747.
12. Shroff R, Eden AA, Pilch D, Ira G, Bonner WM, Petrini JH, Haber JE, Lichten M. Distribution and dynamics of chromatin modification induced by a defined DNA double-strand break. Curr Biol 2004, 14:1703-1711. 10.1016/j.cub.2004.09.047, 15458641.
13. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998, 273:5858-5868. 10.1074/jbc.273.10.5858, 9488723.
14. Ward IM, Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 2001, 276:47759-47762. 10.1074/jbc.M009785200, 11673449.
15. Hanasoge S, Ljungman M. H2AX phosphorylation after UV-irradiation is triggered by DNA repair intermediates and is mediated by the ATR kinase. Carcinogenesis 2007, 28:2298-2304. 10.1093/carcin/bgm157, 17615256.
16. Hunt CR, Pandita RK, Laszlo A, Higashikubo R, Agarwal M, Kitamura T, Gupta A, Rief N, Horikoshi N, Baskaran R, Lee JH, Löbrich M, Paull TT, Roti JL, Pandita TK. Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status. Cancer Res 2007, 67:3010-3017. 10.1158/0008-5472.CAN-06-4328, 17409407.
17. Baure J, Izadi A, Suarez V, Giedzinski E, Cleaver JE, Fike JR, Limoli CL. H2AX phosphorylation in response to changes in chromatin structure induced by altered osmolarity. Mutagenesis 2009, 24:161-167. 10.1093/mutage/gen064, 2648872, 19064695.
18. Chanoux RA, Yin B, Urtishak KA, Asare A, Bassing CH, Brown EJ. ATR and H2AX cooperate in maintaining genome stability under replication stress. J Biol Chem 2009, 284:5994-6003. 10.1074/jbc.M806739200, 2645842, 19049966.
19. Newsham IF. The long and short of chromosome 11 in breast cancer. Am J Pathol 1998, 153:5-9. 10.1016/S0002-9440(10)65538-1, 1852943, 9665458.
20. Evans MF, Koreth J, Bakkenist CJ, Herrington CS, McGee JO. Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia. Oncogene 1998, 16:2557-2564. 10.1038/sj.onc.1202039, 9627121.
21. O'Sullivan MJ, Rader JS, Gerhard DS, Li Y, Trinkaus KM, Gersell DJ, Huettner PC. Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix. Hum Pathol 2001, 32:475-478.
22. Parikh RA, White JS, Huang X, Schoppy DW, Baysal BE, Baskaran R, Bakkenist CJ, Saunders WS, Hsu LC, Romkes M, Gollin SM. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2007, 46:761-775. 10.1002/gcc.20462, 17492757.
23. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lönn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009, 41:899-904. 10.1038/ng.407, 19578367.
24. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Diffilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero DR, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science 2002, 296:922-927. 10.1126/science.1069398, 11934988.
25. Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC, Monroe BC, Ciccone DN, Yan C, Vlasakova K, Livingston DM, Ferguson DO, Scully R, Alt FW. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA 2002, 99:8173-8178. 10.1073/pnas.122228699, 123040, 12034884.
26. Lal A, Pan Y, Navarro F, Dykxhoorn DM, Moreau L, Meire E, Bentwich Z, Lieberman J, Chowdhury D. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 2009, 16:492-498. 10.1038/nsmb.1589, 2853019, 19377482.
27. Jovanovic M, Hengartner MO. miRNAs and apoptosis: RNAs to die for. Oncogene 2006, 25:6176-6187. 10.1038/sj.onc.1209912, 17028597.
28. Wang Y, Lee CG. MicroRNA and cancer: focus on apoptosis. J Cell Mol Med 2009, 13:12-23. 10.1111/j.1582-4934.2008.00510.x, 19175697.
29. Chhabra R, Dubey R, Saini N. Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer 2010, 9:232-247. 10.1186/1476-4598-9-232, 2940846, 20815877.
30. Qin W, Shi Y, Zhao B, Yao C, Jin L, Ma J, Jin Y. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PloS One 2010, 5:e9429. 10.1371/journal.pone.0009429, 2828487, 20195546.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
32. geNorm software. , http://medgen.ugent.be/~jvdesomp/genorm/
33. Pictar. , http://pictar.mdc-berlin.de/
34. miRbase. , http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/
35. TargetScan. , http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/
36. microRNA. , http://www.microrna.org/microrna/home.do
37. microCosom. , http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/
38. Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009, 458:591-596. 10.1038/nature07849, 2692521, 19234442.
39. Xiao A, Li H, Shechter D, Ahn SH, Fabrizio LA, Erdjument-Bromage H, Ishibe-Murakami S, Wang B, Tempst P, Hofmann K, Patel DJ, Elledge SJ, Allis CD. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature 2009, 457:57-62. 10.1038/nature07668, 2854499, 19092802.
40. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991, 88:6961-6965. 10.1073/pnas.88.16.6961, 52213, 1871110.
41. Hsu SY, Hsueh AJ. Bcl-2 protein partners in apoptosis: an ovarian paradigm. Physiol Rev 2000, 80:593-614.
42. Fragkos M, Jurvansuu J, Beard P. H2AX is required for cell cycle arrest via the p53/p21 pathway. Mol Cell Biol 2009, 29:2828-2840. 10.1128/MCB.01830-08, 2682023, 19273588.
43. Enge M, Bao W, Hedström E, Jackson SP, Moumen A, Selivanova G. MDM2-dependent downregulation of p21 and hnRNP K provides a switch between apoptosis and growth arrest induced by pharmacologically activated p53. Cancer Cell 2009, 15:171-183. 10.1016/j.ccr.2009.01.019, 19249676.
44. Shmueli A, Oren M. Mdm2: p53's lifesaver?. Mol Cell 2007, 25:794-796. 10.1016/j.molcel.2007.03.006, 17386256.
45. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69:1237-1245. 10.1016/0092-8674(92)90644-R, 1535557.
46. Bendjennat MBJ, Boulaire J, Jascur T, Brickner H, Barbier V, Sarasin A, Fotedar A, Fotedar R. UV irradiation triggers ubiquitin-dependent degradation of p21 (WAF1) to promote DNA repair. Cell 2003, 114:599-610. 10.1016/j.cell.2003.08.001, 13678583.
47. Weiss RH. p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 2003, 4:425-429. 10.1016/S1535-6108(03)00308-8, 14706334.
48. Tu K, Yu H, Hua YJ, Li YY, Liu L, Xie L, Li YX. Combinatorial network of primary and secondary microRNA-driven regulatory mechanisms. Nucleic Acids Res 2009, 37:5969-5980. 10.1093/nar/gkp638, 2764428, 19671526.